Science

$Andrea Lancia: Hypofractionated radiotherapy for localized prostate cancer in the elderly$

Prostate Cancer/lifelinecelltech.com

Mar 21, 2025, 10:22

Andrea Lancia: Hypofractionated radiotherapy for localized prostate cancer in the elderly

Andrea Lancia, Radiation Oncologist and Medical Director of Oncologic Radiotherapy at I.R.C.C.S. Foundation San Matteo Polyclinic, shared a post on LinkedIn about a paper he co-authored with colleagues published in Prostate Cancer and Prostatic Diseases:

“Hot off the press!

HypoFx RT for localized PCa in the elderly (>74 years): a secondary analysis from the IPOPROMISE cohort.

Data from 719 patients available.

Excellent Outcomes and Safety profiles.”

“Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study”

Authors: Gianluca Ingrosso, Eleonora Festa, Saverio Caini, Elisabetta Ponti, Giulio Francolini, Chiara Doccioli, Andrea Lancia, Annamaria Vinciguerra, Lorenzo Livi, Cynthia Aristei, Beatrice Detti et al.

$Andrea Lancia: Hypofractionated radiotherapy for localized prostate cancer in the elderly$

More posts featuring Andrea Lancia.

Andrea Lancia Annamaria Vinciguerra Beatrice Detti cancer Chiara Doccioli Cynthia Aristei Eleonora Festa Elisabetta Ponti Gianluca Ingrosso Giulio Francolini Hypofractionated radiotherapy IPOPROMISE study localized prostate cancer Lorenzo Livi OncoDaily Oncology prostate cancer Prostate Cancer and Prostatic Diseases Saverio Caini

Changing the Future of Adolescent and Young Adult Cancer Care

OncoDaily Launches New Social Channel on Telegram – @OncoDaily

In Memory of Chadwick Boseman and His Colon Cancer Battle

Groundbreaking Canadian Cancer Society-funded research aims to reshape the future of advanced cancer

CancerWorld is making a RETURN TO PRINT with its February 2025 issue